DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20193177

Knowledge, attitude and practice among consumers about adverse drug reaction reporting

Jeet J. Patel, Megha K. Shah, Prakruti P. Patel, A. M. Gandhi, Mira K. Desai

Abstract


Background: Background: Adverse Drug Reaction (ADR) reporting by consumers is quite low in India. Assessing knowledge and attitude of consumers regarding ADR reporting and observing practice of ADR reporting among them can help explore probable causes for underreporting of ADRs by consumers.

Methods: This was a cross-sectional study conducted in a tertiary care teaching hospital using investigator-administered questionnaire and interviewing indoor patients of Surgery, Medicine, Obstetrics & Gynaecology and Dermatology departments. The questionnaire was prepared to assess knowledge, attitude and practice of consumers about ADR reporting. Data was analysed using mean, standard deviation and percentages.

Result: A total of 820 consumers of medicines were included. It was found that 32.2% consumers were not aware that a drug can produce adverse effects. After being explained about adverse drug reactions, 94.6% consumers felt that adverse drug reactions should be reported. However, 98.8% consumers were not aware of Pharmacovigilance Programme of India. After consulting about consumer reporting programme, majority of respondents (96.1%) felt that the direct consumer reporting programme helps reporting of ADRs. Moreover, 93.7% of consumers were willing to use it to report ADRs in future. Consumers preferred the Telephonic method with a Toll free number for ADR reporting followed by informing a health care professional.

Conclusion: Poor knowledge and awareness about ADR reporting is the major factor for low to nearly absent ADR reporting by consumers in India.


Keywords


Adverse Drug Reaction, Adverse Drug Reaction Reporting, Consumers, Pharmacovigilance Programme of India

Full Text:

PDF

References


International drug monitoring: the role of national centres. WHO technical report series no.498.

Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother. 2012;46;46(2):169-75.

Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017-25.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5.

World Health Organization. Medicines safety, 2017. Available at: https://www.who.int/medicines/regulation/medicines-safety/en/ (Accessed on 1 October 2017).

WHO Collaborating Centre for International Drug Monitoring; 2018. Available at: https://www.who-umc.org/global-pharmacovigilance/who-programme/. Acessed on 10 July 2018.

Kalaivani M, Kalaiselvan V, Dabhi K, Singh GN. Direct consumer reporting of ADRs to PVPI, a position paper of Indian Pharmacopoeia Commission. Advances in Pharmacoepidemiology& Drug Safety. 2015;4(184):2167-1052.

Mukherjee S, Sen S, Kalaisevan V, Tripathi S. Consumer reporting of adverse drug reactions: A current perspective. Intern J Green Pharmacy. 2016;10(3):136-42.

Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Intern J Risk & Safety in Med. 2003;16(5):19.

Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: A review of published literature and international experience. British J Clin Pharmacol. 2007;63(2):148-56.

Herxheimer A, Crombag R. Direct Patient Reporting of Adverse Drug Reactions A Fifteen-Country Survey & Literature review. Paper Series Reference 01-2010/05 Health Action International (Europe) Amsterdam. Netherlands, May 2010.

De Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: Three years of experience. Drug Safety 2008;31(6):515-24.

Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: A retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Safety. 2009;32(11):1067-74.

Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: A methodological study. British J Clin Pharmacol. 2002;53(2):318-25.

O’Brien MC, Yearwood JL. Decisions Surrounding Adverse Drug Reaction Prescribing: Insights from Consumers and implications for Decision Support. J Res and Practice in Information Technol. 2005;37(1):57-71.

Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, 2017. Available at: http://ipc.gov.in. (Accessed on 11 October 2017).

Kalaiselvan V, Prasad T, Bisht A, Singh S, Singh G. Adverse drug reactions reporting culture in Pharmacovigilance Programme of India. Ind J Med Resea. 2014;140(4):563-4.

Potharaju H. Reporting of Adverse Drug Reactions by Consumers: Rationale and Potential. PHARMBIT. 2010;22(2):110-4.

Pahuja R, Shrivastava B, Sharma P, Kishore K, Mahajan S, Sood R. Awareness on Adverse Drug Reaction Reporting System in India: A Consumer Survey. American J Phytomedicine and Clin Therap. 2014;2(12):1361-9.

Tandon V, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India. Ind J Pharmacol. 2015;47(1):65-71.